Empirical Antibiotic Therapy for Left Shift

Diagnostic Significance of Left Shift

An elevated total band count ≥1500 cells/mm³ has the highest likelihood ratio (14.5) for detecting documented bacterial infection, making it the most reliable indicator among white blood cell parameters 1
A left shift with band neutrophils ≥6% has a likelihood ratio of 4.7 for bacterial infection, even when the total WBC count is normal 1
The presence of leukocytosis (WBC ≥14,000 cells/mm³) or left shift warrants careful assessment for bacterial infection in any patient with suspected infection, with or without fever 1

For infants 8-21 days old with abnormal inflammatory markers and left shift, the American Academy of Pediatrics recommends ampicillin IV 150 mg/kg/day divided every 8 hours PLUS either ceftazidime IV 150 mg/kg/day divided every 8 hours OR gentamicin IV 4 mg/kg every 24 hours 2
For infants 22-60 days old with abnormal inflammatory markers, ceftriaxone IV 50 mg/kg every 24 hours is recommended 2
For adults and elderly patients, the empirical regimen depends on three critical factors: suspected source of infection, healthcare exposure, and clinical severity 3, 4, 5

For intra-abdominal infections, piperacillin/tazobactam 4.5g IV every 6 hours is recommended 6, 3
For uncomplicated diverticulitis with left shift, consider antibiotic therapy for ≤7 days in immunocompromised or elderly patients 6
For critically ill patients or those with septic shock, meropenem 1g IV every 6 hours by extended infusion or continuous infusion is recommended 6, 5

Elderly patients frequently have risk factors for resistant bacteria, including recent healthcare facility exposure, corticosteroid use, organ transplantation, baseline pulmonary/hepatic disease, and prior antimicrobial therapy 5
In elderly patients with organ dysfunction and septic shock, broad empiric antimicrobial therapy should be started immediately 5

After adequate source control, a short course of 3-5 days is reasonable for complicated infections 5
For immunocompetent, non-critically ill patients with adequate source control, 4 days of therapy is appropriate 6

For beta-lactam antibiotics, maintain plasma concentrations above MIC for at least 70% of the dosing interval to increase success rates 8
Administer beta-lactams (cefepime, piperacillin-tazobactam, meropenem, doripenem) by extended infusion over 3-4 hours when treating severe infections, especially with high MIC organisms 8

Reassess antibiotic therapy at 48-72 hours and de-escalate based on clinical improvement and microbiological data 8, 4
Modify initial broad-spectrum therapy once culture results are available to minimize antimicrobial resistance development 5, 4